The University of Texas MD Anderson Cancer Center Site #101 — Houston, Texas

The University of Texas MD Anderson Cancer Center Site #101 is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

The University of Texas MD Anderson Cancer Center Site #101 has participated in 1 clinical trials.

Therapeutic areas: Relapsed/Refractory Peripheral T-cell Lymphoma.

Sponsors: Taiho Oncology, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Houston

Browse all research sites in Texas · View every site in Houston

• The University of Texas MD Anderson Cancer Center /ID# 277929
• UT Health/ Memorial Hermann Hospital
• University of Texas Vanguard Urologic Research Foundation
• Anxiety and Health Research Lab, Substance Use Treatment Clinic, University of Houston
• Texas Children's Hospital West Campus
• The Methodist Hospital Houston
• The University Of Texas at Houston
• Houston Methodist Hospital - 6565 Fannin St
• Ben Taub General Hospital / Baylor College of Medicine/Harris Health System
• Lyndon B. Johnson Hospital (Site 1014), 5656 Kelley Street
• The Methodist Hospital Research Institute; Academic Office of Clinical Trials
• University of Texas Health Sciences Center at Houston - Center for Advanced Heart Failure

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Texas MD Anderson Cancer Center Site #101?

The University of Texas MD Anderson Cancer Center Site #101 has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Texas MD Anderson Cancer Center Site #101 conducted?

The University of Texas MD Anderson Cancer Center Site #101 has 1 clinical trials on record. Their work covers Relapsed/Refractory Peripheral T-cell Lymphoma.

Is The University of Texas MD Anderson Cancer Center Site #101 accredited by Crixeo Clinical Trials?

The University of Texas MD Anderson Cancer Center Site #101 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Texas MD Anderson Cancer Center Site #101?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.